Loading...
•
Jun 30, 2022
Atricure Q2 2022 Earnings Report
Reported an increase in revenue driven by sales across key product lines and a rebound in procedure volumes in Europe and growth in Australia.
Key Takeaways
AtriCure reported a strong second quarter with revenue of $84.5 million, an 18.4% increase year-over-year. The company's U.S. revenue grew by 18.6%, driven by key product lines, while international revenue increased by 17.3%, reflecting a rebound in procedure volumes in Europe and growth in Australia. The company is changing the standard of care for millions of patients globally.
Second quarter revenue was $84.5 million, an 18.4% increase year-over-year.
U.S. revenue increased 18.6% to $71.3 million, driven by sales across key product lines.
International revenue increased 17.3% to $13.3 million, driven mainly by appendage management products.
Basic and diluted net loss per share was $0.32.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
Full year 2022 revenue is projected to be approximately $323 million to $333 million, reflecting growth of approximately 18% to 21% over full year 2021. Management continues to expect full year 2022 adjusted EBITDA to be a loss of approximately $2 million to $4 million, and the full year 2022 adjusted loss per share of approximately $1.07 to $1.12.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...